Latest News


Filter by tags: Iodine-131 Clear all tag filters

31 news articles found

The United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) on 9 March released its 2020 Report, “Levels and effects of radiation exposure due to the accident at the Fukushima Daiichi Nuclear Power Station: Implications of information published since the UNSCEAR 2013 Report”. UNSCEAR Chair Gillian Hirth noted: “Since the UNSCEAR 2013 Report, no adverse health effects among Fukushima residents have been documented that could be directly attributed to radiation exposure from the accident.” Twelve UNSCEAR Member States and one observer contributed with over 30 experts to the 2020 evaluation.

Date: Friday, 12 March 2021
Original article:

Scientists at Russia’s DI Mendeleev University of Chemical Technology (MUCTR) have developed a new technology for the manufacture of a sorbent for the elusive form of radioactive iodine - methyl iodide.

Date: Thursday, 21 January 2021
Original article:

Of the 220 research reactors in operation today, only seven are on the African continent. In other words, with 17.2% of the world population and the strongest expected growth in the coming years, Africans have access to only 3% of the world's nuclear research reactor capacity. Marguerite Leonardi, senior advisor at NPC Consulting & Engineering, and Professor Vincent Lukanda Mwamba, Commissaire Général of the Commissariat Général à l’Energie Atomique, explain why that is a concern and why the research reactor in Kinshasa should be restarted urgently.

Date: Tuesday, 13 October 2020
Original article:

Rusatom Healthcare, part of state nuclear corporation Rosatom, will build Russia’s first radiopharmaceutical plant to meet global GMP good manufacturing practice standards. The new production facility will be in Obninsk at the site of LYa Karpov Scientific Research Institute of Physics & Chemistry (NIFKhl) and will produce drugs for targeted cancer therapy. The design of pharmaceutical production will be carried out by the Central Design and Technological Institute. Pre-design work is planned to be completed this year, for commissioning in 2024  production in early 2025.

Date: Friday, 07 August 2020
Original article:

Belgium’s Institute for Radioelements (IRE) has produced its first commercial molybdenum-99 (Mo-99) low enriched uranium (LEU) batch for the US market.

Date: Friday, 08 May 2020
Original article:

Belgium's Institute of Radioelements (IRE) has produced its first batch of the medical radioisotope molybdenum-99 (Mo-99) using a low-enriched uranium (LEU) target rather than a high-enriched uranium (HEU) one. The use of HEU is seen as a potential nuclear proliferation risk.

Date: Tuesday, 05 May 2020
Original article:

The South African government has replaced the entire board of the South Africa Nuclear Energy Corporation (Necsa) following alleged failures in its statutory duties including legislative non-compliance, non-adherence to shareholder instructions, financial mismanagement and a failure to return the country's radioisotope manufacturing facility to full functionality a year after it was shut down due to safety concerns.

Date: Monday, 10 December 2018
Original article:

Production can resume at NTP Radioisotopes' Pelindaba facilities after receiving the go-ahead from South Africa's National Nuclear Regulator (NNR).

Date: Monday, 19 November 2018
Original article:

Belarus considering building a new research reactor with assistance from Russian state nuclear corporation, Belta news agency reported on 20 July.   

Date: Tuesday, 31 July 2018
Original article:

Rusatom Healthcare (part of Rosatom) on 26 July signed a non-binding agreement with the South African Nuclear Energy Corporation of (Necsa)  to cooperate on non-power applications of nuclear technology, particularly nuclear medicine.

Date: Monday, 30 July 2018
Original article: